Table 2.

Univariate outcomes. Probabilities with 95% confidence intervals are shown

Age Group	20–39 (n=308)	40–49 (N=1,615)	50–59 (N=4,952)	60–69 (N=7,032)	≥70 (N=2,092)	p-value
100-day non-relapse mortality	0%	0 (0–1)%	0%	0 (0–1)%	1 (1–1)%	<0.01
2-year relapse/progression	31 (26–37)%	29 (27–32)%	30 (28–31)%	29 (28–30)%	29 (27–32)%	0.80
2-year progression-free survival	68 (62–74)%	69 (67–72)%	68 (67–70)%	68 (67–69)%	66 (64–68)%	0.44
2-year overall survival	94 (91–97)%	91 (90–93)%	90 (90–91)%	89 (88–89)%	86 (85–88)%	<0.01